STEMI Antithrombotic Therapy: The Evolving Role of P2Y12 Inhibitor Pretreatment in Contemporary Practice

The P2Y12 receptor plays a central role in platelet activation, secretion, and procoagulant activity. The CURE (clopidogrel in unstable angina to prevent recurrent events) trial, conducted in 2001, was the first to effectively demonstrate the benefit of dual anti-aggregation therapy with aspirin and...

Full description

Bibliographic Details
Published in:Reviews in Cardiovascular Medicine
Main Authors: Antonella Tommasino, Vincenzo Fiorentini, Giulia Mattaroccia, Alessandra Scoccia, Emanuele Barbato
Format: Article
Language:English
Published: IMR Press 2024-11-01
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/25/11/10.31083/j.rcm2511416